MELBOURNE, AUSTRALIA and AUCKLAND, NEW ZEALAND--(Marketwire - March 16, 2008) - Living Cell Technologies Limited (ASX: LCT) (PINKSHEETS: LVCLY) today announced that a United States patent has been issued for the company's lead product DiabeCell®, currently in development for Type I diabetes.
